iBio, Inc. (IBIO)
2.11
-0.10
(-4.52%)
USD |
NASDAQ |
Feb 12, 16:00
2.15
+0.04
(+1.90%)
After-Hours: 20:00
iBio EPS Diluted (Quarterly) : -0.0907 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 0.5326 |
| Vor Biopharma, Inc. | -121.63 |
| Recursion Pharmaceuticals, Inc. | -0.363 |
| Senti Biosciences, Inc. | -0.6911 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.993M |
| Total Expenses (Quarterly) | 8.993M |
| Enterprise Value | 22.64M |
| Earnings Yield | -47.68% |
| Normalized Earnings Yield | -46.84 |